UHS to Implement Cerner’s Clinically Driven Revenue Cycle
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Oil market losses easing as nearly 80% of disrupted supply returns, UBS says
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Piper Jaffray Reiterates Overweight as Cerner (CERN) Wins UHS Revenue Cycle Deal
April 7, 2016 7:30 AM EDTPiper Jaffray reiterated an Overweight rating and $70.00 price target on Cerner (NASDAQ: CERN) after the company wins revenue cycle deal with Universal Health Services. UHS's CIO indicated that they chose Cerner as they look "to positively impact their financial goals."
Analyst Sean... More
